Adient (NYSE:ADNT) Given New $20.00 Price Target at UBS Group

Adient (NYSE:ADNT - Free Report) had its target price upped by UBS Group from $19.00 to $20.00 in a report released on Wednesday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock.

Several other equities analysts also recently weighed in on the stock. Bank of America downgraded shares of Adient from a "buy" rating to a "neutral" rating and lowered their price target for the company from $30.00 to $24.00 in a report on Thursday, November 21st. Morgan Stanley decreased their target price on Adient from $21.00 to $19.00 and set an "underweight" rating on the stock in a research note on Thursday, November 14th. JPMorgan Chase & Co. lowered their price target on Adient from $24.00 to $21.00 and set a "neutral" rating on the stock in a report on Monday. Wells Fargo & Company lowered shares of Adient from an "overweight" rating to an "equal weight" rating and cut their price objective for the company from $27.00 to $20.00 in a report on Monday, December 16th. Finally, StockNews.com downgraded shares of Adient from a "buy" rating to a "hold" rating in a report on Wednesday, January 22nd. One investment analyst has rated the stock with a sell rating and nine have given a hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $21.88.

Adient Trading Up 0.6 %

NYSE:ADNT traded up $0.10 during mid-day trading on Wednesday, reaching $18.25. 1,420,433 shares of the company's stock traded hands, compared to its average volume of 1,431,417. The company has a 50 day moving average price of $18.01 and a 200-day moving average price of $20.60. The firm has a market capitalization of $1.55 billion, a price-to-earnings ratio of 79.36, a PEG ratio of 0.28 and a beta of 2.16. The company has a debt-to-equity ratio of 0.98, a current ratio of 1.11 and a quick ratio of 0.90. Adient has a 12-month low of $16.28 and a 12-month high of $36.04.

Adient (NYSE:ADNT - Get Free Report) last posted its quarterly earnings data on Tuesday, January 28th. The company reported $0.27 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.05). Adient had a return on equity of 6.86% and a net margin of 0.12%. During the same quarter in the prior year, the business posted $0.31 EPS. On average, sell-side analysts predict that Adient will post 2.04 earnings per share for the current year.

Insider Buying and Selling

In other Adient news, EVP James Conklin sold 11,500 shares of the company's stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $20.25, for a total transaction of $232,875.00. Following the sale, the executive vice president now directly owns 51,829 shares in the company, valued at $1,049,537.25. This represents a 18.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. 1.30% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Adient

Large investors have recently modified their holdings of the stock. Versant Capital Management Inc boosted its position in shares of Adient by 10,316.7% during the fourth quarter. Versant Capital Management Inc now owns 1,875 shares of the company's stock valued at $32,000 after buying an additional 1,857 shares during the period. R Squared Ltd purchased a new stake in Adient in the fourth quarter worth $32,000. US Bancorp DE lifted its position in shares of Adient by 583.8% during the third quarter. US Bancorp DE now owns 1,860 shares of the company's stock worth $42,000 after purchasing an additional 1,588 shares during the last quarter. Signaturefd LLC boosted its stake in shares of Adient by 493.8% during the third quarter. Signaturefd LLC now owns 2,191 shares of the company's stock valued at $49,000 after purchasing an additional 1,822 shares during the period. Finally, KBC Group NV grew its holdings in shares of Adient by 51.8% in the third quarter. KBC Group NV now owns 3,328 shares of the company's stock worth $75,000 after purchasing an additional 1,136 shares during the last quarter. Institutional investors own 92.44% of the company's stock.

About Adient

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.